Disclaimer:

Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.

Thiamine Hydrochloride, Riboflavin 5-Phosphate Sodium, Pyridoxine Hydrochloride, Dexpanthenol, Niacinamide

×

Overview

What is B-PLEX 100?

DESCRIPTION:

Each mL contains:  Thiamine Hydrochloride 100mg, Riboflavin 5' Phosphate Sodium 2mg, Pyridoxine Hydrochloride 2mg, Dexpanthenol 2mg, Niacinamide 100 mg, with Benzyl Alcohol 2% as preservative in Water for Injection.  Sodium Hydroxide and/or Hydrochloric Acid may have been used to adjust pH.



What does B-PLEX 100 look like?



What are the available doses of B-PLEX 100?

Sorry No records found.

What should I talk to my health care provider before I take B-PLEX 100?

Sorry No records found

How should I use B-PLEX 100?

INDICATIONS AND USAGE:

DOSAGE AND ADMINISTRATION:

PRECAUTIONS

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever the solution and container permint (See How Supplied).


What interacts with B-PLEX 100?

Sorry No Records found


What are the warnings of B-PLEX 100?

Sorry No Records found


What are the precautions of B-PLEX 100?

Sorry No Records found


What are the side effects of B-PLEX 100?

Sorry No records found


What should I look out for while using B-PLEX 100?

CONTRAINDICATIONS:

WARNINGS:


What might happen if I take too much B-PLEX 100?

Sorry No Records found


How should I store and handle B-PLEX 100?

Patients should be reminded to read and follow the accompanying , which should be dispensed with the product.Patients should be reminded to read and follow the accompanying , which should be dispensed with the product.Patients should be reminded to read and follow the accompanying , which should be dispensed with the product.Patients should be reminded to read and follow the accompanying , which should be dispensed with the product.Patients should be reminded to read and follow the accompanying , which should be dispensed with the product.HOW SUPPLIED:Phase separation due to reduced solubility can occur under certain conditions of shipping or storage (e.g. accidental freezing), which may produce visible particles.  Do not use product if these do not redissolve on warming to body temperature and shaking well.Refrigeration of the product may cause darkening of the solution due to the riboflavin content.  The colour does not affect the safety or efficacy of the product. HOW SUPPLIED:Phase separation due to reduced solubility can occur under certain conditions of shipping or storage (e.g. accidental freezing), which may produce visible particles.  Do not use product if these do not redissolve on warming to body temperature and shaking well.Refrigeration of the product may cause darkening of the solution due to the riboflavin content.  The colour does not affect the safety or efficacy of the product. HOW SUPPLIED:Phase separation due to reduced solubility can occur under certain conditions of shipping or storage (e.g. accidental freezing), which may produce visible particles.  Do not use product if these do not redissolve on warming to body temperature and shaking well.Refrigeration of the product may cause darkening of the solution due to the riboflavin content.  The colour does not affect the safety or efficacy of the product.


×

Clinical Information

Chemical Structure

No Image found
Clinical Pharmacology

Non-Clinical Toxicology
CONTRAINDICATIONS:

WARNINGS:

No controlled clinical trials were conducted to investigate potential drug-drug interactions. There is potential for an additive interaction with other concomitantly administered medications with anticholinergic properties, including ATROVENT for oral inhalation.

PRECAUTIONS:

ADVERSE REACTIONS:

Sensitivity to the ingredients listed my occur (See ).  Use should be discontinued upon observance of any untoward reaction.  Pain upon intramuscular injection may be noted.

×

Reference

This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"

While we update our database periodically, we cannot guarantee it is always updated to the latest version.

×

Review

Rate this treatment and share your opinion


Learn about User Reviews

Helpful tips to write a good review:

  1. Only share your first hand experience as a consumer or a care giver.
  2. Describe your experience in the Comments area including the benefits, side effects and how it has worked for you. Do not provide personal information like email addresses or telephone numbers.
  3. Fill in the optional information to help other users benefit from your review.

Reason for Taking This Treatment

(required)

Click the stars to rate this treatment

Effectiveness (required)

This medication has worked for me.




Ease of Use (required)

This medication has been easy for me to use.




Satisfaction (required)

Overall, I have been satisfied with my experience.




Write a brief description of your experience with this treatment:

2000 characters remaining

Optional Information

Help others benefit from your review by filling in the information below.
I am a:
Gender:
×

Professional

Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72
×

Tips

Tips

×

Interactions

Interactions

A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).